Analytical methods for determination of new fluoroquinolones in biological matrices and pharmaceutical formulations by liquid chromatography: a review
Tóm tắt
Từ khóa
Tài liệu tham khảo
Peterson LR (2001) Quinolone molecular structure-activity relationships: what we have learned about improving antimicrobial activity. Clin Infect Dis 33(Suppl 3):S180–S186
Emmerson AM, Jones AM (2003) The quinolones: decades of development and use. J Antimicrob Chemother 51(Suppl 1):13–20
Sharma PC, Jain A, Jain S (2009) Fluoroquinolone antibacterials: a review on chemistry, microbiology and therapeutic prospects. Acta Pol Pharm 66:587–604
Sousa J, Alves G, Fortuna A, Pena A, Lino C, Falcão A (2011) Development and validation of a fast isocratic liquid chromatography method for the simultaneous determination of norfloxacin, lomefloxacin and ciprofloxacin in human plasma. Biomed Chromatogr 25:535–541
Oliphant CM, Green GM (2002) Quinolones: a comprehensive review. Am Fam Physician 65:455–464
Scheld WM (2003) Maintaining fluoroquinolone class efficacy: review of influencing factors. Emerg Infect Dis 9:1–9
Carlucci G (1998) Analysis of fluoroquinolones in biological fluids by high-performance liquid chromatography. J Chromatogr A 812:343–367
Wise R, Jones S, Das I, Andrews JM (1998) Pharmacokinetics and inflammatory fluid penetration of clinafloxacin. Antimicrob Agents Chemother 42:428–430
Randinitis EJ, Brodfuehrer JI, Eiseman I, Vassos AB (2001) Pharmacokinetics of clinafloxacin after single and multiple doses. Antimicrob Agents Chemother 45:2529–2535
Nakashima M, Uematsu T, Kosuge K, Kusajima H, Ooie T, Masuda Y, Ishida R, Uchida H (1995) Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans. Antimicrob Agents Chemother 39(12):2635–2640
Aminimanizani A, Beringer P, Jelliffe R (2001) Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials. Clin Pharmacokinet 40(3):169–187
Zhanel GG, Noreddin AM (2001) Pharmacokinetics and pharmacodynamics of the new fluoroquinolones: focus on respiratory infections. Curr Opin Pharmacol 1:459–463
Yoo BK, Triller DM, Yong CS, Lodise TP (2004) Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections. Ann Pharmacother 38:1226–1235
Turnidge J (1999) Pharmacokinetics and pharmacodynamics of fluoroquinolones. Drugs 58(Suppl 2):29–36
Martin SJ, Meyer JM, Chuck SK, Jung R, Messick CR, Pendland SL (1998) Levofloxacin and sparfloxacin: new quinolone antibiotics. Ann Pharmacother 32:320–336
Yamaki KI, Hasegawa T, Matsuda I, Nadai M, Aoki H, Takagi K (1997) Pharmacokinetic characteristics of a new fluoroquinolone, pazufloxacin, in elderly patients. J Infect Chemother 3:97–102
Pazufloxacin mesylate intravenous infusion (2010) PAZFLO leaflet. http://cipladoc.com/therapeutic/pdf_cipla/pazflo.pdf . Accessed 6 Aug 2011
Nakashima M, Uematsu T, Kosuge K, Umemura K, Hakusui H, Tanaka M (1995) Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteers. Antimicrob Agents Chemother 39:170–174
O’Grady J, Briggs A, Atarashi S, Kobayashi H, Smith RL, Ward J, Ward C, Milatovic D (2001) Pharmacokinetics and absolute bioavailability of sitafloxacin, a new fluoroquinolone antibiotic, in healthy male and female Caucasian subjects. Xenobiotica 31:811–822
Ritz M, Lode H, Fassbender M, Borner K, Koeppe P, Nord CE (1994) Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora. Antimicrob Agents Chemother 38:455–459
Montay G (1996) Pharmacokinetics of sparfloxacin in healthy volunteers and patients: a review. J Antimicrob Chemother 37(Suppl A):27–39
Granneman GR, Carpentier P, Morrison PJ, Pernet AG (1991) Pharmacokinetics of temafloxacin in humans after single oral doses. Antimicrob Agents Chemother 35:436–441
Minami R, Nakamura C, Inotsume N, Nakano M (1998) Effects of aluminum hydroxide and famotidine on bioavailability of tosufloxacin in healthy volunteers. Antimicrob Agents Chemother 42:453–455
Teng R, Dogolo LC, Willavize SA, Friedman HL, Vincent J (1997) Oral bioavailability of trovafloxacin with and without food in healthy volunteers. J Antimicrob Chemother 39(Suppl B):87–92
Vincent J, Venitz J, Teng R, Baris BA, Willavize SA, Polzer RJ, Friedman HL (1997) Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin. J Antimicrob Chemother 39(Suppl B):75–80
Vincent J, Teng R, Dalvie DK, Friedman HL (1998) Pharmacokinetics and metabolism of single oral doses of trovafloxacin. Am J Surg 176(Suppl 6A):8S–13S
Matera MG (2006) Pharmacologic characteristics of prulifloxacin. Pulm Pharmacol Ther 19(Suppl 1):20–29
Garraffo R, Lavrut T, Durant J, Héripret L, Sérini MA, Dunais B, Dellamonica P (2005) In vivo comparative pharmacokinetics and pharmacodynamics of moxifloxacin and levofloxacin in human neutrophils. Clin Drug Investig 25:643–650
Blondeau JM (1999) Expanded activity and utility of the new fluoroquinolones: a review. Clin Ther 21:3–40
Brighty KE, Gootz TD (1997) The chemistry and biological profile of trovafloxacin. J Antimicrob Chemother 39(Suppl B):1–14
Blondeau JM (2004) Fluoroquinolones: mechanism of action, classification, and development of resistance. Surv Ophthalmol 49(Suppl 2):S73–S78
Falagas ME, Bliziotis IA, Rafailidis PI (2007) Do high doses of quinolones decrease the emergence of antibacterial resistance? A systematic review of data from comparative clinical trials. J Infect 55:97–105
Ball P (2003) Adverse drug reactions: implications for the development of fluoroquinolones. J Antimicrob Chemother 51(Suppl 1):21–27
Babić S, Horvat AJM, Pavlović DM, Kaštelan-Macan M (2007) Determination of pK a values of active pharmaceutical ingredients. Trends Analyt Chem 26:1043–1061
Hu J, Wang W, Zhu Z, Chang H, Pan F, Lin B (2007) Quantitative structure-activity relationship model for prediction of genotoxic potential for quinolone antibacterials. Environ Sci Technol 41:4806–4812
Robinson AA, Belden JB, Lydy MJ (2005) Toxicity of fluoroquinolone antibiotics to aquatic organisms. Environ Toxicol Chem 24:423–430
Singh BK, Parwate DV, Shukla SK (2009) Rapid color test identification system for screening of counterfeit fluoroquinolone. E-J Chem 6:377–384
Hirota M, Totsu T, Adachi F, Kamikawa K, Watanabe J, Kanegasaki S, Nakata K (2001) Comparison of antimycobacterial activity of grepafloxacin against Mycobacterium avium with that of levofloxacin: accumulation of grepafloxacin in human macrophages. J Infect Chemother 7:16–21
Cárceles CM, Villamayor L, Escudero E, Marín P, Fernández-Varón E (2007) Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats. Vet J 173:452–455
Phapale PB, Lee HW, Kim SD, Lim MS, Kale DD, Lee JM, Park JH, Moon SO, Yoon YR (2010) Analysis of pazufloxacin mesilate in human plasma and urine by LC with fluorescence and UV detection, and its application to pharmacokinetic study. Chromatographia 71:101–106
Araki T, Kawai Y, Ohta I, Kitaoka H (2002) Photochemical behavior of sitafloxacin, fluoroquinolone antibiotic, in an aqueous solution. Chem Pharm Bull 50:229–234
Kamberi M, Kamberi P, Hajime N, Uemura N, Nakamura K, Nakano S (1999) Determination of sparfloxacin in plasma and urine by a simple and rapid liquid chromatographic method. Ther Drug Monit 21:411–415
Ross DL, Elkinton SK, Riley CM (1992) Physicochemical properties of the fluoroquinolone antimicrobials. III. 1-Octanol/water partition coefficients and their relationships to structure. Int J Pharm 88:379–389
Belal F, Al-Majed AA, Al-Obaid AM (1999) Methods of analysis of 4-quinolone antibacterials. Talanta 50:765–786
Takács-Novák K, Jósan M, Hermecz I, Szász (1992) Lipophilicity of antibacterial fluoroquinolones. Int J Pharm 79:89–96
Sun J, Sakai S, Tauchi Y, Deguchi Y, Chen J, Zhang R, Morimoto K (2002) Determination of lipophilicity of two quinolone antibacterials, ciprofloxacin and grepafloxacin, in the protonation equilibrium. Eur J Pharm Biopharm 54:51–58
Andersson MI, MacGowan AP (2003) Development of the quinolones. J Antimicrob Chemother 51(Suppl 1):1–11
Kamberi M, Kamberi P, Nakano S (2000) Determination of grepafloxacin in plasma and urine by a simple and rapid high-performance liquid chromatographic method. J Chromatogr B Biomed Sci Appl 741:295–300
Nguyen HA, Grellet J, Ba BB, Quentin C, Saux MC (2004) Simultaneous determination of levofloxacin, gatifloxacin and moxifloxacin in serum by liquid chromatography with column switching. J Chromatogr B Analyt Technol Biomed Life Sci 810:77–83
Srinivas N, Narasu L, Shankar BP, Mullangi R (2008) Development and validation of a HPLC method for simultaneous quantitation of gatifloxacin, sparfloxacin and moxifloxacin using levofloxacin as internal standard in human plasma: application to a clinical pharmacokinetic study. Biomed Chromatogr 22:1288–1295
Roy B, Das A, Bhaumik U, Sarkar AK, Bose A, Mukharjee J, Chakrabarty US, Das AK, Pal TK (2010) Determination of gemifloxacin in different tissues of rat after oral dosing of gemifloxacin mesylate by LC-MS/MS and its application in drug tissue distribution study. J Pharm Biomed Anal 52:216–226
Gupta H, Aqil M, Khar RK, Ali A, Chander P (2010) A single reversed-phase UPLC method for quantification of levofloxacin in aqueous humour and pharmaceutical dosage forms. J Chromatogr Sci 48:484–490
Borner K, Borner E, Lode H (1992) Determination of sparfloxacin in serum and urine by high-performance liquid chromatography. J Chromatogr 579:285–289
Teng R, Tensfeldt TG, Liston TE, Foulds G (1996) Determination of trovafloxacin, a new quinolone antibiotic, in biological samples by reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Appl 675:53–59
Al-Dgither S, Alvi SN, Hammami MM (2006) Development and validation of an HPLC method for the determination of gatifloxacin stability in human plasma. J Pharm Biomed Anal 41:251–255
Guo L, Qi M, Jin X, Wang P, Zhao H (2006) Determination of the active metabolite of prulifloxacin in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 832:280–285
Nemutlu E, Kir S, Ozyuncu O, Beksac MS (2007) Simultaneous separation and determination of seven quinolones using HPLC: analysis of levofloxacin and moxifloxacin in plasma and amniotic fluid. Chromatographia 66(Suppl 1):S15–S24
Pellegrino RM, Segoloni F, Cagini C (2008) Simultaneous determination of ciprofloxacin and the active metabolite of prulifloxacin in aqueous human humor by high-performance liquid chromatography. J Pharm Biomed Anal 47:567–574
Hemanth Kumar AK, Ramachandran G (2009) Simple and rapid liquid chromatography method for determination of moxifloxacin in plasma. J Chromatogr B Analyt Technol Biomed Life Sci 877:1205–1208
Koechlin C, Jehl F, Linger L, Monteil (1989) High-performance liquid chromatography for the determination of three new fluoroquinolones, fleroxacin, temafloxacin and A-64730, in biological fluids. J Chromatogr 491:379–387
Ocaña González JA, Jiménez Palacios FJ, Callejón Mochón M, Barragán de la Rosa FJ (2004) Simultaneous determination of cefepime and grepafloxacin in human urine by high-performance liquid chromatography. J Pharm Biomed Anal 36:117–123
Baietto L, D’Avolio A, De Rosa FG, Garazzino S, Patanella S, Siccardi M, Sciandra M, Di Perri G (2009) Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV. Ther Drug Monit 31:104–109
Wright DH, Herman VK, Konstantinides FN, Rotschafer JC (1998) Determination of quinolone antibiotics in growth media by reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 709:97–104
Liang H, Kays MB, Sowinski KM (2002) Separation of levofloxacin, ciprofloxacin, gatifloxacin, moxifloxacin, trovafloxacin and cinoxacin by high-performance liquid chromatography: application to levofloxacin determination in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 772:53–63
Overholser BR, Kays MB, Sowinski KM (2003) Determination of gatifloxacin in human serum and urine by high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Analyt Technol Biomed Life Sci 798:167–173
US DHHS, FDA and CDER (2001) Guidance for industry: bioanalytical method validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research and Center for Veterinary Medicine. http://www/fda.gov/cder/guidance/index.htm . Accessed 10 May 2011
Gupta H, Aqil M, Khar RK, Ali A, Sharma A, Chander P (2010) Development and validation of a stability-indicating RP-HPLC method for the quantitative analysis of sparfloxacin. J Chromatogr Sci 48:1–6
Engler M, Rüsing G, Sörgel F, Holzgrabe U (1998) Defluorinated sparfloxacin as a new photoproduct identified by liquid chromatography coupled with UV detection and tandem mass spectrometry. Antimicrob Agents Chemother 42:1151–1159
Lovdahl MJ, Priebe SR (2000) Characterization of clinafloxacin photodegradation products by LC-MS/MS and NMR. J Pharm Biomed Anal 23:521–534
Yoshida Y, Sato E, Moroi R (1993) Photodegradation products of levofloxacin in aqueous solution. Arzneimittelforschung 43:601–606
Fasani E, Rampi M, Albini A (1999) Photochemistry of some fluoroquinolones: effect of pH and chloride ion. J Chem Soc, Perkin Trans 2:1901–1907
Albini A, Monti S (2003) Photophysics and photochemistry of fluoroquinolones. Chem Soc Rev 32:238–250
Eurachem (1998) The fitness for purpose of analytical methods: a laboratory guide to method validationand related topics. LGC, Teddington. http://www.eurachem.org/guides/pdf/valid.pdf . Accessed 23 May 2011
Nováková L, Vlcková H (2009) A review of current trends and advances in modern bio-analytical methods: chromatography and sample preparation. Anal Chim Acta 656:8–35
Unceta N, Goicolea MA, Barrio RJ (2011) Analytical procedures for the determination of the selective serotonin reuptake inhibitor antidepressant citalopram and its metabolites. Biomed Chromatogr 25:238–257
Kole PL, Venkatesh G, Kotecha J, Sheshala R (2011) Recent advances in sample preparation techniques for effective bioanalytical methods. Biomed Chromatogr 25:199–217
Roy B, Choudhury H, Das A, Das AK, Pal TK (2011) Development and validation of a liquid chromatography-tandem mass spectrometry method to determine ulifloxacin, the active metabolite of prulifloxacin in rat and rabbit plasma: application to toxicokinetic study. Biomed Chromatogr 25:890–901
Fang PF, Cai HL, Li HD, Zhu RH, Tan QY, Gao W, Xu P, Liu YP, Zhang WY, Chen YC, Zhang F (2010) Simultaneous determination of isoniazid, rifampicin, levofloxacin in mouse tissues and plasma by high performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 878:2286–2291
Jain GK, Jain N, Pathan SA, Akhter S, Talegaonkar S, Chander P, Khar RK, Ahmad FJ (2010) Ultra high-pressure liquid chromatographic assay of moxifloxacin in rabbit aqueous humor after topical instillation of moxifloxacin nanoparticles. J Pharm Biomed Anal 52:110–113
Noh K, Kwon KI, Jeong TC, Kang W (2010) Quantitative determination of sparfloxacin in rat plasma by liquid chromatography/tandem mass spectrometry. Biomed Chromatogr 24:1199–1202
Watabe S, Yokoyama Y, Nakazawa K, Shinozaki K, Hiraoka R, Takeshita K, Suzuki Y (2010) Simultaneous measurement of pazufloxacin, ciprofloxacin, and levofloxacin in human serum by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 878:1555–1561
De Smet J, Boussery K, Colpaert K, De Sutter P, De Paepe P, Decruyenaere J, Van Bocxlaer J (2009) Pharmacokinetics of fluoroquinolones in critical care patients: a bio-analytical HPLC method for the simultaneous quantification of ofloxacin, ciprofloxacin and moxifloxacin in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 877:961–967
Rambla-Alegre M, Esteve-Romero J, Carda-Broch S (2009) Validation of a MLC method with fluorescence detection for the determination of quinolones in urine samples by direct injection. J Chromatogr B Analyt Technol Biomed Life Sci 877:3975–3981
Rote AR, Pingle SP (2009) Reverse phase-HPLC and HPTLC methods for determination of gemifloxacin mesylate in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 877:3719–3723
Robledo VR, Smyth WF (2008) A study of the analytical behaviour of selected new molecular entities using electrospray ionisation ion trap mass spectrometry, liquid chromatography, gas chromatography and polarography and their determination in serum at therapeutic concentrations. Anal Chim Acta 623:221–230
Gao X, Yao G, Guo N, An F, Guo X (2007) A simple and rapid high performance liquid chromatography method to determine levofloxacin in human plasma and its use in a bioequivalence study. Drug Discov Ther 1:136–140
Pea F, Marioni G, Pavan F, Staffieri C, Bottin R, Staffieri A, Furlanut M (2007) Penetration of levofloxacin into paranasal sinuses mucosa of patients with chronic rhinosinusitis after a single 500 mg oral dose. Pharmacol Res 55:38–41
Tasso L, Dalla Costa T (2007) High performance liquid chromatography for quantification of gatifloxacin in rat plasma following automated on-line solid phase extraction. J Pharm Biomed Anal 44:205–210
Tatar Ulu S (2007) High-performance liquid chromatography assay for moxifloxacin: pharmacokinetics in human plasma. J Pharm Biomed Anal 43:320–340
Wen J, Zhu Z, Hong Z, Wu Y, Fei Y, Lin M, Fan G, Wu Y (2007) Determination of the active metabolite of prulifloxacin in human plasma by HPLC with fluorescence detection. Chromatographia 66:37–41
Zhou ZL, Yang M, Yu XY, Peng HY, Shan ZX, Chen SZ, Lin QX, Liu XY, Chen TF, Zhou SF, Lin SG (2007) A rapid and simple high-performance liquid chromatography method for the determination of human plasma levofloxacin concentration and its application to bioequivalence studies. Biomed Chromatogr 21:1045–1051
Ji HY, Jeong DW, Kim YH, Kim HH, Sohn DR, Lee HS (2006) Hydrophilic interaction liquid chromatography-tandem mass spectrometry for the determination of levofloxacin in human plasma. J Pharm Biomed Anal 41:622–627
Laban-Djurdjević A, Jelikić-Stankov M, Djurdjević P (2006) Optimization and validation of the direct HPLC method for the determination of moxifloxacin in plasma. J Chromatogr B Analyt Technol Biomed Life Sci 844:104–111
Salazar Cavazos ML, Colunga González LY, Gallegos de Lerma G, Waksman de Torres N (2006) Determination of gatifloxacin in semen by HPLC with diode-array and fluorescence detection. Chromatographia 63:605–608
Schulte S, Ackermann T, Bertram N, Sauerbruch T, Paar WD (2006) Determination of the newer quinolones levofloxacin and moxifloxacin in plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr Sci 44:205–208
Siewert S (2006) Validation of a levofloxacin HPLC assay in plasma and dialysate for pharmacokinetic studies. Pharm Biomed Anal 41:1360–1362
Ocaña González JA, Callejón Mochón M, Barragán de la Rosa FJ (2005) Simultaneous determination of cefepime and the quinolones garenoxacin, moxifloxacin and levofloxacin in human urine by HPLC-UV. Microchim Acta 151:39–45
Djabarouti S, Boselli E, Allaouchiche B, Ba B, Nguyen AT, Gordien JB, Bernadou JM, Saux MC, Breilh D (2004) Determination of levofloxacin in plasma, bronchoalveolar lavage and bone tissues by high-performance liquid chromatography with ultraviolet detection using a fully automated extraction method. J Chromatogr B Analyt Technol Biomed Life Sci 799:165–172
Pea F, Di Qual E, Cusenza A, Brollo L, Baldassarre M, Furlanut M (2003) Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia. Clin Pharmacokinet 42:589–598
Gehanno P, Darantière S, Dubreuil C, Chobaut JC, Bobin S, Pages JC, Renou G, Bobin F, Arvis P, Stass H (2002) A prospective, multicentre study of moxifloxacin concentrations in the sinus mucosa tissue of patients undergoing elective surgery of the sinus. J Antimicrob Chemother 49:821–826
Neckel U, Joukhadar C, Frossard M, Jäger W, Müller M, Mayer BX (2002) Simultaneous determination of levofloxacin and ciprofloxacin in microdialysates and plasma by high-performance liquid chromatography. Anal Chim Acta 463:199–206
Böttcher S, von Baum H, Hoppe-Tichy T, Benz C, Sonntag HG (2001) An HPLC assay and a microbiological assay to determine levofloxacin in soft tissue, bone, bile and serum. J Pharm Biomed Anal 25:197–203
Du LM, Fan ZF, Qiao JL, Wang JP (2001) Determination of sparfloxacin in human urine by reversed-phase high performance liquid chromatography with nitrous acid and hydroiodic pre-column derivatization. Chin Chem Lett 12:1007–1010
Vishwanathan K, Bartlett MG, Stewart JT (2001) Determination of gatifloxacin in human plasma by liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun Mass Spectrom 15:915–919
Borner K, Hartwig H, Lode H (2000) Determination of gatifloxacin in human serum and urine by HPLC. Chromatographia 52(Suppl 1):S105–S107
Doyle E, Fowles SE, McDonnell DF, McCarthy R, White SA (2000) Rapid determination of gemifloxacin in human plasma by high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Biomed Sci Appl 746:191–198
Lemoine T, Breilh D, Ducint D, Dubrez J, Jougon J, Velly JF, Saux MC (2000) Determination of moxifloxacin (BAY 12-8039) in plasma and lung tissue by high-performance liquid chromatography with ultraviolet detection using a fully automated extraction method with a new polymeric cartridge. J Chromatogr B Biomed Sci Appl 742:247–254
Perez-Olivan S, Solans C, García MA, Pinilla I, Honrubia F, Bregante MA (2000) Determination of grepafloxacin in plasma samples by HPLC: application to clinical pharmacokinetic studies. Chromatographia 51:25–28
Borner K, Hartwig H, Lode H (1999) Determination of trovafloxacin in human body fluids by high-performance liquid chromatography. J Chromatogr A 846:175–180
Kamberi M, Hajime N, Kamberi P, Uemura N, Nakamura K, Nakano S (1999) Simultaneous determination of grepafloxacin, ciprofloxacin, and theophylline in human plasma and urine by HPLC. Ther Drug Monit 21:335–340
Brodfuehrer JI, Priebe S, Guttendorf R (1998) Achiral and chiral high-performance liquid chromatographic methods for clinafloxacin, a fluoroquinolone antibacterial, in human plasma. J Chromatogr B Biomed Sci Appl 709:265–272
Mody VD, Pandya KK, Satia MC, Modi IA, Modi RI, Gandhi TP (1998) High performance thin-layer chromatographic method for the determination of sparfloxacin in human plasma and its use in pharmacokinetic studies. J Pharm Biomed Anal 16:1289–1294
Stass H, Dalhoff A (1997) Determination of BAY 12-8039, a new 8-methoxyquinolone, in human body fluids by high-performance liquid chromatography with fluorescence detection using on-column focusing. J Chromatogr B Biomed Sci Appl 702:163–174
Wong FA, Juzwin SJ, Flor SC (1997) Rapid stereospecific high-performance liquid chromatographic determination of levofloxacin in human plasma and urine. J Pharm Biomed Anal 15:765–771
Matsuoka M, Banno K, Sato T (1996) Analytical chiral separation of a new quinolone compound in biological fluids by high-performance liquid chromatography. J Chromatogr B Biomed Appl 676:117–124
Aoki H, Ohshima Y, Tanaka M, Okazaki O, Hakusui H (1994) High-performance liquid chromatographic determination of the new quinolone antibacterial agent DU-6859a in human serum and urine using solid-phase extraction with photolysis-fluorescence detection. J Chromatogr B Biomed Appl 660:365–374
Granneman GR, Varga LL (1991) High-performance liquid chromatographic procedures for the determination of temafloxacin in biological matrices. J Chromatogr 568:197–206
Bao D, Truong TT, Renick PJ, Pulse ME, Weiss WJ (2008) Simultaneous determination of rifampicin and levofloxacin concentrations in catheter segments from a mouse model of a device-related infection by liquid chromatography/electrospray ionization tandem mass spectrometry. J Pharm Biomed Anal 46:723–727
Hendriks G (2009) Theoretical models in LC based bioanalytical method development. J Pharm Biomed Anal 49:1–10
Morales-Cid G, Cárdenas S, Simonet BM, Valcárcel M (2009) Fully automatic sample treatment by integration of microextraction by packed sorbents into commercial capillary electrophoresis-mass spectrometry equipment: application to the determination of fluoroquinolones in urine. Anal Chem 81:3188–3193
Burden DW (2008) Guide to the homogenization of biological samples. Random Primers 7:1–14
Marona HR, Schapoval EE (1999) A high-performance liquid chromatographic assay for sparfloxacin. J Pharm Biomed Anal 20:413–417
Santoro MI, Kassab NM, Singh AK, Kedor-Hackmam ER (2006) Quantitative determination of gatifloxacin, levofloxacin, lomefloxacin and pefloxacin fluoroquinolonic antibiotics in pharmaceutical preparations by high-performance liquid chromatography. J Pharm Biomed Anal 40:179–784
Kothekar KM, Jayakar B, Khandhar AP, Mishra RK (2007) Quantitative determination of levofloxacin and ambroxol hydrochloride in pharmaceutical dosage form by reversed- phase high performance liquid chromatography. Eurasian J Anal Chem 2:21–31
Patel SA, Prajapati AM, Patel PU, Patel NJ, Vaghmasi JB (2008) Development and validation of column high-performance liquid chromatographic and derivative spectrophotometric methods for determination of levofloxacin and ornidazole in combined dosage forms. J AOAC Int 91:756–761
Donnenfeld ED, Comstock TL, Proksch JW (2011) Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application. J Cataract Refract Surg 37:1082–1089
Nageswara Rao R, Naidu CG, Prasad KG, Narasimha R (2011) Development and validation of a RP-HPLC method for stability-indicating assay of gemifloxacin mesylate including identification of related substances by LC-ESI-MS/MS, 1H and 13C NMR spectroscopy. Biomed Chromatogr. doi: 10.1002/bmc.1594
Yan H, Row KH (2007) Rapid chiral separation and impurity determination of levofloxacin by ligand-exchange chromatography. Anal Chim Acta 584:160–165
Chen B, Yu Z, Zhang W, Fang J, Cai W (2006) Determination of pazufloxacin in human plasma by RP-HPLC with fluorimetric detection. Chin J Hosp Pharm 9:1104–1106
Sultana N, Arayne MS, Naz A (2006) Development and validation of an HPLC-UV method for the determination of gatifloxacin in bulk material, pharmaceutical formulations, human plasma and metal complexes. Pak J Pharm Sci 19:275–281
Zhang Z, Yang G, Wang D, Liang G, Chen Y (2004) Chiral separation and enantiomeric purity determination of pazufloxacin mesylate by HPLC using chiral mobile phase additives. J Liq Chromatogr Relat Technol 27(5):813–827
Lyon DJ, Cheung SW, Chan CY, Cheng AF (1994) Rapid HPLC assay of clinafloxacin, fleroxacin, levofloxacin, sparfloxacin and tosufloxacin. J Antimicrob Chemother 34:446–448
Kim BH, Choi NH, Ok JH (2002) Comparison of reversed-phase liquid chromatographic methods for the separation of new quinolones. J Chromatogr Sci 40:369–376
Sudo Y (1996) End-capping of octadecylsilylated silica gels by high-temperature silylation. J Chromatogr A 737:139–147
Chamseddin C, Jira TH (2011) Comparison of the chromatographic behavior of levofloxacin, ciprofloxacin, ciprofloxacin and moxifloxacin on various HPLC phases. Pharmazie 66:244–248
Pistos C, Stewart JT (2003) Direct injection HPLC method for the determination of selected benzodiazepines in plasma using a Hisep column. J Pharm Biomed Ana 33:1135–1142
Grellet J, Ba B, Saux MC (2002) High-performance liquid chromatographic separation of fluoroquinolone enantiomers: a review. J Biochem Biophys Methods 54:221–233
Alves G, Fortuna A, Falcão A (2008) High-performance liquid chromatography and its impact in the development of chiral drugs: a review. Trends Chromatogr 4:1–10
Lehr KH, Damn P (1988) Quantification of the enantiomers of ofloxacin in biological fluids by high-performance liquid chromatography. J Chromatogr 425:153–161
Machida M, Izawa S, Hori W, Ishida R, Uchida H (1999) Pharmacokinetics of gatifloxacin, a new quinolone, and its enantiomers: II. Enantioselective method for the determination of gatifloxacin and its application to pharmacokinetic studies in animals. Jpn J Chemother 47(Suppl 2):124–130
Liu XB, An S, Man F, Liang BM (2010) Separation of ulifloxacin enantiomers by HPLC with chiral mobile phase additives. Chin J Pharm Anal 3:435–437
Choi HJ, Cho HS, Han SC, Hyun MH (2009) HPLC of fluoroquinolone antibacterials using chiral stationary phase based on enantiomeric (3,3′-diphenyl-1,1′-binaphthyl)-20-crown-6. J Sep Sci 32:536–541
Lee W, Hong CY (2000) Direct liquid chromatographic enantiomer separation of new fluoroquinolones including gemifloxacin. J Chromatogr A 879:113–120
Hyun MH, Han SC, Cho YJ, Jin JS, Lee W (2002) Liquid chromatographic resolution of gemifloxacin mesylate on a chiral stationary phase derived from crown ether. Biomed Chromatogr 16:356–360
Hyun MH, Han SC, Jin JS, Lee W (2000) Separation of the stereoisomers of racemic fluoroquinolone antibacterial agents on a crown-ether-based chiral HPLC stationary phase. Chromatographia 52:473–476
Sun X, Wu D, Shao B, Zhang J (2009) High-performance liquid-chromatographic separation of ofloxacin using a chiral stationary phase. Anal Sci 25:931–933